Antibiotic pharmacokinetics in infected pleural effusions

Thorax. 2024 Aug 19;79(9):883-885. doi: 10.1136/thorax-2023-220402.

Abstract

Pleural infection is usually treated with empirical broad-spectrum antibiotics, but limited data exist on their penetrance into the infected pleural space. We performed a pharmacokinetic study analysing the concentration of five intravenous antibiotics across 146 separate time points in 35 patients (amoxicillin, metronidazole, piperacillin-tazobactam, clindamycin and cotrimoxazole). All antibiotics tested, apart from co-trimoxazole, reach pleural fluid levels equivalent to levels within the blood and well above the relevant minimum inhibitory concentrations. The results demonstrate that concerns about the penetration of commonly used antibiotics, apart from co-trimoxazole, into the infected pleural space are unfounded.

Keywords: Bacterial Infection; Pleural Disease; Pneumonia; Respiratory Infection.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Anti-Bacterial Agents* / pharmacokinetics
  • Anti-Bacterial Agents* / therapeutic use
  • Female
  • Humans
  • Male
  • Middle Aged
  • Pleural Effusion* / drug therapy
  • Pleural Effusion* / metabolism

Substances

  • Anti-Bacterial Agents